Vascular-dependent effects of elevated glucose on postganglionic sympathetic neurons

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Damon, Deborah H ^a  

^a UNIVERSITY OF VERMONT   (Canada)

Author keywords

Norepinephrine; Sympathetic nervous system; Vascular smooth muscle

Indexed keywords

GLUCOSE; NORADRENALIN; STREPTOZOCIN; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; MALE; NERVE CELL CULTURE; NONHUMAN; NORADRENALIN RELEASE; POSTGANGLIONIC NERVE; POSTGANGLIONIC SYMPATHETIC NEURON; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; SYMPATHETIC NERVE CELL;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FEMORAL ARTERY; GLUCOSE; HYPERGLYCEMIA; MALE; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC FIBERS, POSTGANGLIONIC; TYROSINE 3-MONOOXYGENASE;

EID: 79955068966     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00300.2010     Document Type: Article

References (38)

1. Anonymous. Diabetes mellitus: a major risk factor for cardiovascular disease. A Joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 100: 1132-1133, 1999.
2. Arbin V, Claperon N, Fournie-Zaluski MC, Roques BP, Peyroux J. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin- induced diabetic rats. Br J Pharmacol 130: 1297-1304, 2000.
3. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 45: 1-16, 2008.
4. Baumbach GL, Heistad DD, Siems JE. Effect of sympathetic nerves on composition and distensibility of cerebral arterioles in rats. J Physiol 416: 123-140, 1989.
5. Bevan RD. Influence of adrenergic innervation on vascular growth and mature characteristics. Am Rev Respir Dis 140: 1478-1482, 1989.
6. Bleeke T, Zhange H, Madamanchi N, Patterson C, Faber JE. Catecholamine- induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45, 2004.
7. Burgdorf C, Dendorfer A, Kurz T, Schomig E, Stolting I, Schutte F, Richardt G. Role of neuronal KATP channels and extraneuronal monamine transporter on norepinephrine overflow in a model of low flow ischemia. J Pharmacol Exp Ther 309: 42-48, 2004.
8. Caló LA, Davis PA, Cantaro S, Bonfante L, Castrignano R, Carraro G, D'Angelo A. Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes. Acta Diabetol 35: 96-100, 1998.
9. Campanucci V, Krishnaswamy A, Cooper E. Diabetes depresses synaptic transmission in sympathetic ganglia by inactivating nAChRs through a conserved intracellular cystein residue. Neuron 66: 827-834, 2010.
10. Damon DH. NGF-independent survival of postganglionic sympathetic neurons in neuronal-vascular smooth muscle cocultures. Am J Physiol Heart Circ Physiol 280: H1722-H1728, 2001.
11. Damon DH. TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3. Am J Physiol Cell Physiol 294: C306-C312, 2008.
12. Damon DH, teRiele JA, Marko SB. Vascular-derived artemin: a determinant of vascular sympathetic innervation? Am J Physiol Heart Circ Physiol 293: H266-H273, 2007.
13. Dehal NS, Kartseva A, Weaver LC. Comparison of locations and peptide content of postganglionic neurons innervating veins and arteries of the rat hindlimb. J Auton Nerv Syst 39: 61-72, 1992.
14. Demel SL, Dong H, Swain GM, Wang X, Kreulen DL, Galligan JJ. Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Neuroscience 168: 335-345, 2010.
15. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120: 1-34, 2008.
16. Faraci FM. Hydrogen peroxide: Watery fuel for change in vascular biology. Arterioscler Thromb Vasc Biol 26: 1931-1933, 2006.
17. Fitzgerald SM, Brands MW. Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system. Am J Physiol Regul Integr Comp Physiol 282: R1070-R1076, 2002.
18. Frisbee JC. Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats. Am J Physiol Heart Circ Physiol 290: H2066-H2074, 2006.
19. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
20. Hart JL, Freas W, McKenzie JE, Muldoon SM. Adrenergic nerve function and contractile activity of the caudal artery of the streptozotocin diabetic rat. J Auton Nerv Syst 25: 49-57, 1988.
21. Johnson CD, Coney AM, Marshall JM. Roles of norepinephrine and ATP in sympathetically evoked vasoconstriction in rat tail and hindlimb in vivo. Am J Physiol Heart Circ Physiol 281: H2432-H2440, 2001.
22. Koshimura K, Tanaka J, Murakami Y, Kato Y. Effect of high concentration of glucose on dopamine release from pheochromocytoma-12 cells. Metabolism 52: 922-926, 2003.
23. Levi-Montalcini R, Booker B. Destruction of the sympathetic ganglia in mammals by an antiserum to the nerve growth-promoting factor. Proc Natl Acad Sci USA 46: 384-391, 1960.
24. Marko SB, Damon DH. VEGF promotes vascular sympathetic innervation. Am J Physiol Heart Circ Physiol 294: H2646-H2652, 2008.
25. Martinez-Nieves B, Dunbar JC. Vascular dilatatory responses to sodium nitroprusside (SNP) and alpha-adrenergic antagonism in female and male normal and diabetic rats. Proc Soc Exp Biol Med 222: 90-98, 1999.
26. Minami K, Miki T, Kadowaki T, Seino S. Roles of ATP-sensitive K_ channels as metabolic sensors: Studies of Kir6.x null mice. Diabetes 53: S176-S180, 2004.
27. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 273: H2224-H2231, 1997.
28. Nichols CG. KATP channels as molecular sensors of cellular metabolism. Nature 440: 470-476, 2006.
29. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172-186, 1971.
30. Schmidt RE, Cogswell BE. Tyrosine hydroxylase activity in sympathetic nervous system of rats with streptozocin-induced diabetes. Diabetes 38: 959-968, 1989.
31. Schmidt RE, Plurad SB, Parvin CA, Roth KA. Effect of diabetes and aging on human sympathetic autonomic ganglia. Am J Pathol 143: 143-153, 1993.
32. Schotzinger RJ, Landis SC. Acquisition of cholinergic and peptidergic properties by sympathetic innervation of rat sweat glands requires interaction with normal target. Neuron 5: 91-100, 1990.
33. Semra YK, Smith NC, Lincoln J. Comparative effects of high glucose on different adult sympathetic neurons in cultures. Neuroreport 15: 2321-2325, 2004.
34. Semra YK, Wang M, Peat NJ, Smith NC, Shotton HR, Lincoln J. Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro. Neurosci Lett 407: 199-204, 2006.
35. Speirs L, Donnelly A, Lynch J, Scholfield CN, Johnson C. ATP and norepinephrine contributions to sympathetic vasoconstriction of tail artery are altered in streptozotocin-diabetic rats. Am J Physiol Heart Circ Physiol 291: H2327-H2333, 2006.
36. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 9: 36-45, 2008.
37. Uhrenholt TR, Nedergaard OA. Calcium channels involved in noradrenaline release from sympathetic neurones in rabbit carotid artery. Pharmacol Toxicol 92: 226-233, 2003.
38. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26: 1553-1579, 2003.